Ovarian Neoplasms

3 researchers across 2 institutions

3 Researchers
2 Institutions
0 Grant PIs
1 High Impact

Research in ovarian neoplasms investigates the fundamental biological processes underlying the development and progression of ovarian cancers. This area explores cellular mechanisms, genetic alterations, and molecular pathways that contribute to tumor formation, growth, and metastasis. Studies employ a range of methodologies, including molecular biology techniques, advanced imaging, and computational analysis, to identify novel therapeutic targets and diagnostic markers. Specific interests include understanding the tumor microenvironment, the role of specific gene mutations in cancer development, and the development of more effective treatment strategies.

This work holds significant relevance for Arkansas by addressing critical public health challenges. Ovarian cancer disproportionately affects women, and understanding its mechanisms is vital for improving early detection, treatment outcomes, and patient survival rates within the state's population. Research findings can inform clinical practice and public health initiatives aimed at reducing the burden of this disease. Furthermore, advancements in this field can stimulate innovation in the state's growing biotechnology and healthcare sectors, fostering economic development through the application of new diagnostic and therapeutic technologies.

This research area draws upon and contributes to several related fields, including disease mechanisms, cancer genomics, bioinformatics, and medical research. Collaboration extends across multiple institutions within Arkansas, fostering a multidisciplinary approach to tackling complex questions in ovarian cancer. The engagement of researchers from different institutions ensures a broad perspective and diverse expertise applied to this critical area of study.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Michael Birrer UAMS 27 20,276 Faculty High Impact
Laura F. Mortan Hendrix College 2 17
Danny Baxter UAMS 0 0

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
7,356 works in 2026
+0.9% CAGR 2018–2026
Leadership concentration
5.7% held by global top 5 institutions
Fragmented HHI 22
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2026 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 3,221
  2. 2 Harvard University 2,698
  3. 3 Memorial Sloan Kettering Cancer Center 2,577
  4. 4 Massachusetts General Hospital 2,000
  5. 5 Mayo Clinic 1,743
Browse All 3 Researchers in Directory